Timing of Adjuvant Chemoradiation in pT1-3N1-2 or pT4aN1 Esophageal Squamous Cell Carcinoma After R0 Esophagectomy

INTRODUCTION: Postoperative adjuvant radiation therapy (RT) and chemotherapy (aCRT) have been supposed to improve prognosis and outcomes in patients with node-positive thoracic esophageal squamous cell carcinoma (TESCC). Our aim was to analyze the impacts of interval between surgery and aCRT on prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Leilei, Zhang, Zhenshan, Li, Shuo, Ke, Linping, Yu, Jinming, Meng, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603416/
https://www.ncbi.nlm.nih.gov/pubmed/33149667
http://dx.doi.org/10.2147/CMAR.S276426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603416/
https://www.ncbi.nlm.nih.gov/pubmed/33149667
http://dx.doi.org/10.2147/CMAR.S276426

Ejemplares similares